Financial reports
10-Q
2019 Q2
Quarterly report
6 Aug 19
10-Q
2019 Q1
Quarterly report
2 May 19
10-K
2018 FY
Annual report
25 Feb 19
10-Q
2018 Q3
Quarterly report
5 Nov 18
10-Q
2018 Q2
Quarterly report
7 Aug 18
10-Q
2018 Q1
Quarterly report
8 May 18
10-K
2017 FY
Annual report
26 Feb 18
10-Q
2017 Q3
Quarterly report
7 Nov 17
10-Q
2017 Q2
Quarterly report
8 Aug 17
10-Q
2017 Q1
Quarterly report
27 Apr 17
Current reports
8-K
Entry into a Material Definitive Agreement
22 Oct 19
8-K
Tender and Support Agreement
16 Sep 19
8-K
Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating Results
6 Aug 19
8-K
Submission of Matters to a Vote of Security Holders
24 May 19
8-K
Other Events
2 May 19
8-K
Alder BioPharmaceuticals® Reports First Quarter 2019 Financial and Operating Results
2 May 19
8-K
Departure of Directors or Certain Officers
12 Apr 19
8-K
Departure of Directors or Certain Officers
28 Mar 19
8-K
Departure of Directors or Certain Officers
28 Mar 19
8-K
Entry into a Material Definitive Agreement
5 Mar 19
Registration and prospectus
15-12B
Securities registration termination
1 Nov 19
POSASR
Automatic shelf registration (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
25-NSE
Exchange delisting
22 Oct 19
Proxies
Other
UPLOAD
Letter from SEC
3 Oct 19
CT ORDER
Confidential treatment order
15 Apr 19
CT ORDER
Confidential treatment order
7 Jun 18
CT ORDER
Confidential treatment order
11 Apr 17
EFFECT
Notice of effectiveness
8 Jan 15
CORRESP
Correspondence with SEC
5 Jan 15
CORRESP
Correspondence with SEC
5 Jan 15
UPLOAD
Letter from SEC
30 Dec 14
CT ORDER
Confidential treatment order
8 May 14
EFFECT
Notice of effectiveness
7 May 14
Ownership
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G
Beneficial ownership report
31 Oct 19
SC 13D/A
Alder Biopharmaceuticals Inc
25 Oct 19
4
Carlos Campoy
24 Oct 19
4
PAUL STRECK
24 Oct 19
4
Nadia Dac
24 Oct 19
4
Jeremy Green
24 Oct 19
4
Erin Lavelle
24 Oct 19
4
James B Bucher
24 Oct 19
4
Randal Hassler
24 Oct 19